Gordon Awandare

Last updated

Gordon A Awandare
Prof. Gordon Awandare with his students (2019 graduation).jpg
Gordon Awandare (middle) with his students during 2019 graduation
Born
Gordon Akanzuwine Awandare

Kandiga, Kassena Nankana West District
NationalityGhanaian
Alma materNotre Dame Seminary Senior High School

University of Ghana

University of Pittsburgh
Known forPro-Vice Chancellor of the University of Ghana and Founding Director of WACCBIP
AwardsFellow of Ghana Academy of Arts and Sciences, Royal Society Pfizer Award 2015
Scientific career
FieldsMalaria parasite biology, Immunology, Pathogenesis
InstitutionsUniversity of Ghana, West African Center for Cell Biology of Infectious Pathogens, Walter Reed Army Institute of Research, University of Pittsburgh
Thesis Role of Macrophage Migration Inhibitory Factor (MIf) And MIf Promoter Polymorphisms in the Pathogenesis of Severe Malarial Anemia  (2007)
Doctoral advisor Douglas J. Perkins
Website https://www.waccbip.org/staffs/gordon-awandare/

Gordon Akanzuwine Awandare is a Ghanaian parasitologist and the Pro-Vice Chancellor in charge of Academic and Student Affairs at the University of Ghana. Prior to his appointment in January 2022, He was the founding Director of the West African Center for Cell Biology of Infectious Pathogens (WACCBIP). [1] He is the current chairman of the CKT-UTAS governing council [2] and the Africa Global Editor of the Experimental Biology and Medicine (EBM) journal.

Contents

Early life and education

Gordon Awandare was born in Kandiga, a small village in northeastern Ghana. During childhood, he contracted malaria several times a year, at a time when treatment for the disease was scarce. [3]

Awandare was awarded a BSc in biochemistry in 1998 and an MPhil in Biochemistry in 2002 from the University of Ghana. [4] In 2003, he was alerted to PhD positions at the University of Pittsburgh (Pennsylvania, USA) earmarked for African fellows, and moved to the USA just eight months later. [4] In 2007, he graduated with a PhD in Infectious Diseases and Microbiology from the School of Public Health, with a thesis on severe malarial anemia. Following his doctoral studies, he spent three years at the Walter Reed Army Institute of Research (Maryland, USA), where he continued studying malaria, focusing on the Plasmodium falciparum parasite.[ citation needed ]

He returned to the University of Ghana in 2010 to establish his own research group. [4] Without start-up funding, he used US credit cards to support his work whilst applying for grants, and two years later received funding from both the Royal Society and the National Institutes of Health.[ citation needed ]

University Leadership and Management

Prof Awandare was appointed Pro Vice-Chancellor with responsibility for Academic and Student Affairs (ASA). [5] The appointment took effect from 1 January 2022. Taking over from Prof. Daniel Frimpong Ofori, Provost of the College of Humanities who was appointed to act as Pro-Vice-Chancellor (ASA) from 27 October 2021. [6] He has previously served on the Governing Council of the University of Development Studies, Tamale, where he was also the Chairman of the University’s Audit Report Implementing Committee. Within the University of Ghana, he has been a member of Academic Board and served on the Business and Executive Committee for many years. Prof. Awandare has also been Chairman, Centre Management Committee for WACCBIP, and member of Management committees/boards for many units, including, Office of Research Innovation and Development (ORID), Noguchi Memorial Institute for Medical Research, School of Pharmacy, Legon Centre for International Affairs and Diplomacy, School of Biological Sciences, and School of Nuclear and Allied Sciences, Ghana Atomic Energy Commission. He has also chaired or served on numerous adhoc committees at the University of Ghana, including the Search Committee for Vice Chancellor in 2020/2021. [7]

Parasitology research

Awandare's research focuses on the malaria parasite Plasmodium falciparum and the infection it causes in children. His work focuses on both the immune response of the patient to infection, and the pathogenic processes of the parasite itself. In particular, he studies cell-surface receptors that could be potential vaccine targets [8] and his studies use parasites from infected children in Ghana, so that any vaccines developed will be applicable to real-life cases. He was the first to report the possibility of parasite phenotypic switching in invitro cultures when shaken. [9] Prof. Awandare also led significant research into molecular diagnosis of infectious diseases in lower income setting in Africa. [10] In addition, He is significantly pushing for policy change in tackling hearing impairment in Ghana. [11]

During the 2020 COVID-19 global pandemic, Awandare led a group of scientist at the University of Ghana and the Noguchi Memorial Institute of Medical Research to sequence SARS-COV2 virus isolates from Ghanaian patients. [12] In January 2021, He reported the importation of the UK strain of the virus in travellers arriving in Ghana from other African countries. [13] [14] Awandare advocated for the re-imposition of ban on large funerals and weddings to reduce COVID-19 case spike in early 2021. [15]

WACCBIP

In 2013, Awandare led a consortium from the University of Ghana in a proposal to set up a new African Centre of Excellence to research infectious pathogens in Africa. The consortium consisted of faculty from the Department of Biochemistry, Cell and Molecular Biology (BCMB) and the Noguchi Memorial Institute for Medical Research (NMIMR), with support from staff of the University of Ghana Computing Systems (UGCS). Following the award of $8 million from the World Bank in November 2013, Awandare became the Founding Director of The West African Center for Cell Biology of Infectious Pathogens (WACCBIP). The organization has since received further funding from the World Bank ACE project and the Wellcome Trust DELTAS programme. The mission of WACCBIP is to "improve the diagnosis, prevention, and control of tropical diseases in sub-Saharan Africa by providing advanced-level training and research excellence in cell and molecular biology", [16] with a remit to build capacity by training African scientists at masters, doctoral and post-doctoral levels. The center has expanded to study malaria, Buruli ulcer, HIV, and tuberculosis.  

Awards and recognition

In 2015, Awandare was awarded the Royal Society Africa Prize, which recognises innovative biological research scientists whose research also contributes towards significant capacity building in Africa. The award was made for "achievements in molecular and cellular studies of malaria, including how malaria parasites invade red blood cells and cause disease". [17] Prof. Gordon Awandare is a visiting professor of immunology at the Oxford Brookes University in the UK in February 2019. [18] He is the current board chairman of the CK Tedam University of Technology and Applied Sciences (CKT-UTAS) governing council. CKT-UTAS is the newly caved out of university from the University for Development Studies in the Upper East Region of Ghana. [19] Previously, He was the government appointee on the University for Development Studies governing council. [20] Prof. Gordon Awandare is also the Network's Chairman of the established West African Network of Infectious Diseases ACEs (WANIDA), which will aim to enhance collaboration among West African health research institutions funded under the World Bank's African Centres of Excellence (ACE) Impact project. [21] In 2014, He was awarded the University of Ghana's Distinguished Award for Meritorious Service at 2014 Congregation. [22] [23] He is a fellow of the Ghana Academy of Arts and Sciences. [24] Professor Gordon Awandare has been named the first Africa Global Editor of the Experimental Biology and Medicine (EBM) journal [25]

Grants

Awandare has been a recipient and lead of several internationally competitive grants;

YearFunderDescriptionAmount
2012National Institute of Allergy and Infectious DiseasesRole of Complement Receptor 1 in Erythrocyte Invasion by Plasmodium Falciparum [26] US$42,322
2013World Bank GroupAfrica Centers of Excellence Project I for the establishment of WACCBIP [27] US$8.0M
2015Wellcome TrustWellcome Trust's Developing Excellence in Leadership, Training and Science (DELTAS) Africa Initiative [28] £7.1M
2017National Institute for Health Research (NIHR)TIBA (Rapid Impact Project and Making a Difference Project) [29] £100,000
2017UK Global Challenges Research Fund (GCRF)The Crick African Network's African Career Accelerator (CAN ACA) [30] £1,6M
2019World Bank GroupAfrica Centers of Excellence Impact Project [31]

Related Research Articles

<span class="mw-page-title-main">Malaria</span> Mosquito-borne infectious disease

Malaria is a mosquito-borne infectious disease that affects humans and other vertebrates. Human malaria causes symptoms that typically include fever, fatigue, vomiting, and headaches. In severe cases, it can cause jaundice, seizures, coma, or death. Symptoms usually begin 10 to 15 days after being bitten by an infected Anopheles mosquito. If not properly treated, people may have recurrences of the disease months later. In those who have recently survived an infection, reinfection usually causes milder symptoms. This partial resistance disappears over months to years if the person has no continuing exposure to malaria.

<i>Plasmodium</i> Genus of parasitic protists that can cause malaria

Plasmodium is a genus of unicellular eukaryotes that are obligate parasites of vertebrates and insects. The life cycles of Plasmodium species involve development in a blood-feeding insect host which then injects parasites into a vertebrate host during a blood meal. Parasites grow within a vertebrate body tissue before entering the bloodstream to infect red blood cells. The ensuing destruction of host red blood cells can result in malaria. During this infection, some parasites are picked up by a blood-feeding insect, continuing the life cycle.

<i>Plasmodium falciparum</i> Protozoan species of malaria parasite

Plasmodium falciparum is a unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans. The parasite is transmitted through the bite of a female Anopheles mosquito and causes the disease's most dangerous form, falciparum malaria. It is responsible for around 50% of all malaria cases. P. falciparum is therefore regarded as the deadliest parasite in humans. It is also associated with the development of blood cancer and is classified as a Group 2A (probable) carcinogen.

<i>Plasmodium vivax</i> Species of single-celled organism

Plasmodium vivax is a protozoal parasite and a human pathogen. This parasite is the most frequent and widely distributed cause of recurring malaria. Although it is less virulent than Plasmodium falciparum, the deadliest of the five human malaria parasites, P. vivax malaria infections can lead to severe disease and death, often due to splenomegaly. P. vivax is carried by the female Anopheles mosquito; the males do not bite.

<span class="mw-page-title-main">Joseph DeRisi</span> American biochemist

Joseph Lyman DeRisi is an American biochemist, specializing in molecular biology, parasitology, genomics, virology, and computational biology.

Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which annually affects an estimated 247 million people worldwide and causes 619,000 deaths. The first approved vaccine for malaria is RTS,S, known by the brand name Mosquirix. As of April 2023, the vaccine has been given to 1.5 million children living in areas with moderate-to-high malaria transmission. It requires at least three doses in infants by age 2, and a fourth dose extends the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30%.

<span class="mw-page-title-main">RTS,S</span> Malaria vaccine

RTS,S/AS01 is a recombinant protein-based malaria vaccine. It is one of two malaria vaccines approved. As of April 2022, the vaccine has been given to 1 million children living in areas with moderate-to-high malaria transmission, with millions more doses to be provided as the vaccine's production expands. 18 million doses have been allocated for 2023-2025. It requires at least three doses in infants by age 2, with a fourth dose extending the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30% and reduces toddler deaths by 15%.

Russell J. Howard is an Australian-born executive, entrepreneur and scientist. He was a pioneer in the fields of molecular parasitology, especially malaria, and in leading the commercialisation of one of the most important methods used widely today in molecular biology today called “DNA shuffling" or "Molecular breeding", a form of "Directed evolution".

<span class="mw-page-title-main">Brendan Crabb</span> Australian scientist (born 1966)

Brendan Scott CrabbFASM is an Australian microbiologist, research scientist and director and chief executive officer of the Burnet Institute, based in Melbourne, Victoria, Australia.

<span class="mw-page-title-main">Leann Tilley</span> Australian biochemist and microbiologist

Leann Tilley is Professor of Biochemistry and Molecular Biology in the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne.

Sanaria is a biotechnology company developing vaccines protective against malaria and other infectious diseases as well as related products for use in malaria research. Sanaria's vaccines are based on the use of the sporozoite (SPZ) stage of the malaria parasite, Plasmodium, as an immunogen, and as a platform technology for liver-vectored gene delivery. SPZ are normally introduced into humans by mosquito bite where they migrate to the liver and further develop to liver stages, and eventually back into the blood stream where the parasite infects red blood cells (RBC) and causes malaria. Plasmodium falciparum is the species responsible for more than 95% deaths caused by malaria. The WHO estimates there were 247 million clinical cases and 619,000 deaths in 2021 alone.

Adrianus Mattheus Dondorp is a Dutch intensivist, infectious diseases physician, and head of the Mahidol Oxford Tropical Medicine Research Unit in Bangkok. He is best known for his research in severe falciparum malaria, a disease that requires intensive care in hospital. He chairs the World Health Organization Technical Expert Group on antimalarial medication drug resistance and containment.

Deepak Gaur was an Indian molecular biologist, and a professor at the School of Biotechnology of Jawaharlal Nehru University. Known for his studies on Plasmodium falciparum, Gaur is a recipient of the N-Bios Prize. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, for his contributions to medical sciences in 2017.

Utpal Shashikant Tatu is an Indian molecular biologist, biochemist and a professor and Chairman of the department of biochemistry of the Indian Institute of Science. He is known for his research on infectious disease such as malaria and other neglected tropical diseases of global relevance. He is one of the first proponents of "One Health" concept to control infectious disease outbreaks. Tatu is an elected fellow of the Indian Academy of Sciences. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2008. Tatu is a proponent of the One Health approach. The 'One Health' approach advocates designing and implementing strategies, policies and carrying out scientific research which involves collaboration between multiple sectors that will lead to major public health outcomes.

Alan Frederick Cowman AC, FRS, FAA, CorrFRSE, FAAHMS, FASP, FASM is an internationally acclaimed malaria researcher whose work specialises in researching the malaria-causing parasite, Plasmodium falciparum, and the molecular mechanisms it uses to evade host responses and antimalarial drugs. He is currently deputy directory of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, and his laboratory continues to work on understanding how Plasmodium falciparum, infects humans and causes disease. He was elected as a fellow of the Royal Society in 2011 and awarded the Companion of the Order of Australia in 2019 for his "eminent service to the biological sciences, notably to molecular parasitology, to medical research and scientific education, and as a mentor."

Isabella Akyinbah Quakyi is a Ghanaian academic. She is a professor of Immunology and Parasitology at the University of Ghana and the Foundation Dean of the University of Ghana School of Public Health. She is also a researcher in the field of medicine and a health practitioner. She is a fellow of the Ghana Academy of Arts and Sciences, and a fellow of the African Academy of Sciences. Professor Quakyi was recognized by Newsweek magazine as one of “seven women scientists who defied the odds and changed science forever”.

<span class="mw-page-title-main">Christian Happi</span>

Christian Happi is a Professor of Molecular Biology and Genomics in the Department of Biological Sciences and the Director of the African Centre of Excellence for Genomics of Infectious Diseases, both at Redeemer’s University. He is known for leading the team of scientists that used genomic sequencing to identify a single point of infection from an animal reservoir to a human in the Ebola outbreak in West Africa. His research focus is on infectious diseases, including malaria, Lassa fever, Ebola virus disease, HIV, and SARS-CoV-2.

Stephen L. Hoffman is an American physician-scientist, tropical medicine specialist and vaccinologist, who is the founder and chief executive and scientific officer of Sanaria Inc., a company dedicated to developing PfSPZ vaccines to prevent malaria.

Aditya Prasad Dash, who hails from the Indian State of Odisha, is an Indian biologist with special interest in malaria and vector borne diseases. His areas of interest include biomedical science, transmission biology of tropical disease, and modern biology of disease vectors. According to Vidwan, the national network for researchers and experts, Dash has authored 320 publications co-authored 699 publications. Since September 2020, Dash has been serving as the Vice Chancellor of Asian Institute of Public Health (AIPH) in Bhubaneswar. Before joining AIPH, he was the Vice Chancellor of Central University of Tamil Nadu during the period from August 2015 to August 2020. He had also worked at the World Health Organization (WHO) as the Regional Advisor for the South-East Region. He has also worked as the Director of the National Institute of Malaria Research (NIMR), New Delhi, of the Institute of Life Sciences (ILS), Bhubaneswar and of the National Institute for Research on Tribal Health, Jabalpur.

David A. Fidock, is the CS Hamish Young Professor of Microbiology and Immunology and Professor of Medical Sciences at Columbia University Irving Medical Center in Manhattan.

References

  1. ↑ "Gordon A. Awandare (BSc, MPhil (Ghana), PhD (Pittsburgh)) | Department of Biochemistry, Cell and Molecular Biology". University Of Ghana. Retrieved 2019-02-08.
  2. ↑ "The University Council - C.K.Tedam University Of Technology & Applied Sciences" . Retrieved 2021-01-20.
  3. ↑ "Gordon Awandare: Ghana's Homecoming King". The Scientist Magazine®. Retrieved 2018-11-09.
  4. 1 2 3 "Dr Gordon A Awandare | Royal Society". royalsociety. Retrieved 2018-11-09.
  5. ↑ "Professor Awandare appointed substantive UG Pro-VC". GhanaWeb. 2021-12-24. Retrieved 2022-03-11.
  6. ↑ "Professor Awandare appointed as Pro VC, Academic and Student Affairs, University of Ghana - MyJoyOnline.com". Myjoyonline. 2021-12-24. Retrieved 2022-03-11.
  7. ↑ "Prof. Gordon A. Awandare Appointed Pro-VC ASA | University of Ghana". University Of Ghana. Retrieved 2022-03-11.
  8. ↑ "Ghanaian Scientists Discover Target for Malaria Vaccine". 99Science. 2021-01-08. Retrieved 2021-01-20.
  9. ↑ Awandare, Gordon A.; Nyarko, Prince B.; Aniweh, Yaw; Ayivor-Djanie, Reuben; Stoute, José A. (2018-04-10). "Plasmodium falciparum strains spontaneously switch invasion phenotype in suspension culture". Scientific Reports. 8 (1): 5782. Bibcode:2018NatSR...8.5782A. doi:10.1038/s41598-018-24218-0. ISSN   2045-2322. PMC   5893586 . PMID   29636510.
  10. ↑ Yaw, Aniweh; Prosper, Kanyong; Krampa, Francis; Awandare, Gordon A. (2018-07-11). "Local diagnostics kits for Africa being developed in Ghana". Nature. 559 (7713): 181. Bibcode:2018Natur.559..181Y. doi: 10.1038/d41586-018-05666-0 . PMID   29991789.
  11. ↑ Adadey, Samuel M.; Quaye, Osbourne; Amedofu, Geoffrey K.; Awandare, Gordon A.; Wonkam, Ambroise (2020). "Screening for GJB2-R143W-Associated Hearing Impairment: Implications for Health Policy and Practice in Ghana". Public Health Genomics. 23 (5–6): 184–189. doi: 10.1159/000512121 . ISSN   1662-4246. PMID   33302283.
  12. ↑ "News Release - University of Ghana Scientists Sequence Genomes of Novel Coronavirus | University of Ghana". University of Ghana. Retrieved 2021-01-20.
  13. ↑ Ngoi, Joyce M.; Quashie, Peter K.; Morang'a, Collins M.; Bonney, Joseph Hk; Amuzu, Dominic Sy; Kumordjie, Selassie; Asante, Ivy A.; Bonney, Evelyn Y.; Eshun, Miriam; Boatemaa, Linda; Magnusen, Vanessa (2020-12-16). "Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana". Experimental Biology and Medicine. 246 (8): 960–970. doi:10.1177/1535370220975351. ISSN   1535-3699. PMC   7746953 . PMID   33325750.
  14. ↑ "Ghana record new strain of Covid-19 as infections rise catch 200 new cases daily". BBC News Pidgin. Retrieved 2021-01-20.
  15. ↑ "Re-impose ban on large funerals, weddings to reduce Covid-19 spike – Prof. Awandre - MyJoyOnline.com". Myjoyonline. Retrieved 2021-01-20.
  16. ↑ "Overview – WACCBIP". waccbip. Retrieved 2018-11-09.
  17. ↑ "2015 Royal Society Pfizer Award Seminar | Royal Society". royalsociety. Retrieved 2021-01-20.
  18. ↑ "Oxford Brookes University bioimaging scientists collaborate with researchers in Ghana to create a centre of excellence - Oxford Brookes University". Oxford Brookes University United Kingdom. Retrieved 2021-01-20.
  19. ↑ "Governing councils of 3 universities sworn in". Graphic Online. Retrieved 2021-01-20.
  20. ↑ "Minister swears in UDS new governing council". Modern Ghana. Retrieved 2021-01-20.
  21. ↑ "UG, WACCBIP to host new West African network for health research – WACCBIP" . Retrieved 2021-01-20.
  22. ↑ "Two UG lecturers awarded for Meritorious service - MyJoyOnline.com". Myjoyonline. Retrieved 2021-01-20.
  23. ↑ "Joint Award for Distinguished Award for Meritorious Service 2013: Prof. Eric Danquah and Dr. Gordon Awandare | University of Ghana". University of Ghana. Retrieved 2021-01-20.
  24. ↑ "GAAS Fellow co-leads team of Ghanaian scientists to sequence genomes of novel corona virus – Ghana Academy of Arts and Sciences" . Retrieved 2021-01-20.
  25. ↑ "WACCBIP Director Named First EBM Journal Global Editor for Africa | University of Ghana". University of Ghana. Retrieved 2021-01-20.
  26. ↑ "RePORT ⟩ RePORTER". reporter nih of government. Retrieved 2021-01-20.
  27. ↑ "WACCBIP – ACE – African Higher Education Centres of Excellence" . Retrieved 2021-01-20.
  28. ↑ "Grantees Profile | The AAS". Aasciences Africa. Retrieved 2021-01-20.
  29. ↑ "Principal Investigators | TIBA". tiba-partnership. Retrieved 2021-01-20.
  30. ↑ "Accelerator Awards". Crick. Retrieved 2021-01-20.
  31. ↑ "ACE Impact Centers – ACE – African Higher Education Centres of Excellence" . Retrieved 2021-01-20.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.